Pharmaceutical giant AstraZeneca has struck a deal with Europe’s Inclusive Vaccines Alliance to supply up to 400 million doses of an experimental Covid-19 vaccine, as efforts to boost manufacturing capacity continue at pace.
The alliance, which was forged by Germany, France, Italy and the Netherlands to speed up production of a vaccine, is set to take delivery of the material being tested by the University of Oxford by the end of 2020.
{iframe}https://amp-breakingnews-ie.cdn.ampproject.org/c/s/amp.breakingnews.ie/world/astrazeneca-agrees-to-make-covid-19-vaccine-for-europe-1005120.html{/iframe}